Biogazelle

Biogazelle is a Belgian life science company focused on RNA-based biomarker discovery, assay development, genomic testing, and transcriptomic services for diagnostics, therapeutics, and clinical trials. The company has built expertise in non-coding RNA, liquid biopsies, qPCR, dPCR, and RNA sequencing, and operates accredited laboratory services for research and clinical sample analysis. Its offerings are primarily service-based rather than centered on proprietary therapeutic drug programs, with an emphasis on biomarker development and data analysis for precision medicine. Biogazelle was acquired by CellCarta in December 2021 and has been integrated within CellCarta NV while continuing to be associated with specialized genomic capabilities.